Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement
23 mai 2024 07h30 HE
|
Rakovina Therapeutics Inc
All monetary figures listed in Canadian Dollars. VANCOUVER, British Columbia, May 23, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a...
Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research
08 mai 2024 08h00 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new...
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
26 avr. 2024 20h38 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, April 26, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based...
Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today
09 avr. 2024 16h05 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), (“Rakovina” or the “Company”), a biopharmaceutical company dedicated to improving the lives...
Rakovina Therapeutics To Host Informational Webinar on April 3, 2024
01 avr. 2024 07h15 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), (“Rakovina Therapeutics” or the “Company”), a biopharmaceutical company dedicated to...
Rakovina Therapeutics Announces Strategic Pivot to AI
27 mars 2024 16h05 HE
|
Rakovina Therapeutics Inc
Rakovina Therapeutics announces Artificial Intelligence (AI) collaboration
Rakovina Therapeutics Inc. Announces Q3 2023 Financial Results and Provides Corporate Update
27 nov. 2023 19h43 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company dedicated to improving the lives of cancer patients...
Rakovina Therapeutics Welcomes Prof. Artem Cherkasov to the Company’s Scientific Advisory Board
27 nov. 2023 09h00 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company focused on the development of novel DNA-damage...
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
20 nov. 2023 09h13 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company focused on the development of novel DNA-damage...
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update
29 août 2023 08h00 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company dedicated to improving the lives of cancer patients...